Page last updated: 2024-08-17

nad and Burkitt Lymphoma

nad has been researched along with Burkitt Lymphoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Di Stefano, G; Govoni, M; Manerba, M; Vettraino, M1
Salord, J; Schuber, F1

Other Studies

2 other study(ies) available for nad and Burkitt Lymphoma

ArticleYear
Galloflavin suppresses lactate dehydrogenase activity and causes MYC downregulation in Burkitt lymphoma cells through NAD/NADH-dependent inhibition of sirtuin-1.
    Anti-cancer drugs, 2013, Volume: 24, Issue:8

    Topics: Adenosine Triphosphate; Burkitt Lymphoma; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Enzyme Inhibitors; Histone Deacetylase Inhibitors; Humans; Inhibitory Concentration 50; Isocoumarins; Isoenzymes; L-Lactate Dehydrogenase; Lactate Dehydrogenase 5; Lactic Acid; NAD; Proto-Oncogene Proteins c-myc; Signal Transduction; Sirtuin 1; Time Factors

2013
In vitro drug delivery mediated by ecto-NAD+-glycohydrolase ligand-targeted liposomes.
    Biochimica et biophysica acta, 1988, Sep-16, Volume: 971, Issue:2

    Topics: Ammonium Chloride; Animals; Antineoplastic Agents; Burkitt Lymphoma; Cell Division; Cell Line; Deoxyuridine; Drug Carriers; Fibroblasts; Humans; Kinetics; Liposomes; Methotrexate; Mice; N-Glycosyl Hydrolases; NAD; NAD+ Nucleosidase; Sulfhydryl Compounds; Tumor Cells, Cultured

1988